News | 01/10/2019 | Press Release, Award

Award for Groundbreaking Research on Alzheimer’s Disease

SyNergy member Christian Haass has received the “Hartwig Piepenbrock-DZNE Prize” endowed with 60,000 euros. The company Piepenbrock and the German Center for Neurodegenerative Diseases (DZNE) thereby honor his groundbreaking research into the molecular mechanisms of Alzheimer’s disease.

“Christian Haass is one of the world’s leading experts on the molecular mechanisms of Alzheimer’s disease,” said Professor Pierluigi Nicotera, Chairman of the DZNE’s Executive Board. “We owe him groundbreaking insights into proteins and immune reactions involved in Alzheimer’s disease. Christian Haass has thus laid the foundations for new approaches in therapy and diagnosis. He has played a key role in Alzheimer’s research over the past 30 years and continues to do so today.”